The system is designed to help reduce snoring severity. It was previously approved for the treatment of snoring and sleep apnea. The new approval allows ENT surgeons to use up to five Pillar implants specifically for snoring, which the company said will help patients with wider mouths and softer palate tissue.
“The National Sleep Foundation estimates that nearly 90 million American adults are affected by snoring,” said Janis Saunier, marketing director for the surgical technologies division at Medtronic, in the release. “We’re pleased that we can now offer the Pillar procedure to patients who previously were not candidates.”
Medtronic is headquartered in Minneapolis.
Related Articles on FDA Clearances:
Kimberly-Clark Health Care Receives FDA Clearance for Sterilization Wrap Portfolio
Flexible Stenting Solutions Receives FDA Clearance for New Sizes of Stent System
Links Medical Receives FDA Clearance for Wound Care Products
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.